136471-99-3

Upstream product

• 54497-89-1 methyl 2,6-bis-α-D-glucopyranoside 
• 160835-77-8 methyl 6-deoxy-3,4-bis(O-methoxymethyl)-α-D-xylo-hex-5-enopyranoside 
• 136471-96-0 Methyl 6-deoxy-3,4-bis-O-(methoxymethyl)-2-O-(p-toluenesulfonyl)-α-D-xylo-5-hexenopyranoside 
• 136471-95-9 methyl 3,4-bis(O-methoxymethyl)-2,6-bis-α-D-glucopyranoside 
• 100-39-0 benzyl bromide 
• 97-30-3 methyl-alpha-D-glucopyranoside 
• 136471-97-1 methyl 2-O-benzyl-6-deoxy-3,4-bis(O-methoxymethyl)-α-D-xylo-hex-5-enopyranoside 
• 136471-98-2 (2S,3R,4S)-4-Benzyloxy-5-hydroxy-2,3-bis-methoxymethoxy-cyclohexanone 

Downstream Products

• 171815-12-6 <1S-(1α,2β,3α,4β)>-4-(Benzyloxy)-2,3-bis(methoxymethoxy)-5-cyclohexen-1-ol 
• 1053628-75-3 (1S,2S,3S,4S,5R,6R)-3-Amino-5,6-bis-methoxymethoxy-cyclohexane-1,2,4-triol 
• 171815-15-9 <1S-(1α,2α,3β,4β,5α,6β)>-3-Azido-5,6-bis(methoxymethoxy)cyclohexane-1,2,4-triol 
• 171815-13-7 <1R-(1α,2β,3α,4β,5α,6α)>-5-(Benzyloxy)-3,4-bis(methoxymethoxy)-7-oxabicyclo<4.1.0>heptan-2-ol 
• 171815-18-2 2,3,4,6-Tetra-O-benzyl-1-deoxy-1-<<<3aS-(3aα,4α,5α,6β,7α,7aα)>-4,5,6,7-tetrahydroxy-3a,4,5,6,7,7a-hexahydrobenzoxazol-2-yl>amino>-α-D-glucopyranose 
• 171815-17-1 N-<<1S-(1α,2β,3α,4β,5β,6α)>-1,2,3,4,5-Pentahydroxycyclohex-6-yl>-N'-(2,3,4,6-tetra-O-α-D-glucopyranosyl)thiourea 
• 104873-76-9 2,3,6-tris-O-(phenylmethyl)-D-myo-inositol 
• 136472-00-9 1D-(1,3/2,4)-1,4-di-O-benzyl-2,3-bis(O-methoxymethyl)-5-cyclohexene-1,2,3,4-tetrol 
• 136522-41-3 1D-3,6-di-O-benzyl-4,5-bis(O-methoxymethyl)-1,2,3,5/4,6-cyclohexanehexol 
• 136472-01-0 1D-2,3,6-tri-O-benzyl-1,4,5-tris(O-methoxymethyl)-1,2,3,5/4,6-cyclohexanehexol 
• 160835-78-9 1D-3,6-di-O-benzyl-1,4,5-tris(O-methoxymethyl)-1,2,3,5/4,6-cyclohexanehexol 

Relevant academic research and scientific papers

Synthesis of a 2-aminohexahydrobenzoxazole analogue related to trehazolin

2-Aminohexahydrobenzoxazole analogue 1a, related to trehazolin (2) was synthesized using the Ferrier reaction as a key step. The structural elucidation of this compound by NMR analysis indicated that it is an inseparable mixture of three components (1a-c) which in turn stems from the propensity of la to partially undergo both transcyclization (1a → 1b) of the aminooxazoline between the hydroxy group at the C-1 position of aminocyclitol in the aglycon moiety and the hydroxy group at the C-2 position of D-glucose moiety and successive transformation (1b → 1c) of the D-glucose moiety from a pyranose to a furanose structure.

Syntheses of Optically Active 2,3,6-Tri-O-benzyl-D-myo-inositol, Laminitol, and Mytilitol from D-Glucose

2,3,6-Tri-O-benzyl-D-myo-inositol, which is a key intermediate of D-inositol 1,4,5-triphosphate, was synthesized from D-glucose without performing any optical resolution by utilizing C2 symmetry.Laminitol and mytilitol were also synthesized from D-glucose

Synthesis of Optically Active 2,3,6-Tri-O-benzyl-D-myo-inositol from D-Glucose

The title compound was synthesized from D-glucose as a key intermediate of D-Inositol-1,4,5-triphosphate synthesis without doing any optical resolution by utilizing C2 symmetry.